Shandong Weigao Blood Purification Products (603014.SH): The issuance of shares to purchase assets will be discussed in the meeting on August 10.
Weigao Xuejing (603014.SH) announced that the company plans to issue shares to acquire 100% equity of Shandong Weigao Puri Pharmaceutical Packaging Co., Ltd. According to the Shanghai Stock Exchange M&A Review Committee's announcement on the 16th review meeting in 2026, the committee is scheduled to convene on August 10, 2026, to review the company's application for this transaction.
Shandong Weigao Blood Purification Products (603014.SH) announced that the company intends to issue shares to acquire 100% equity of Shandong Weigao Prei Pharmaceutical Packaging Co., Ltd. According to the announcement from the Shanghai Stock Exchange Mergers and Acquisitions Review Committee regarding the 16th review meeting of 2026, the review committee is scheduled to hold the 16th Mergers and Acquisitions Review Committee meeting on August 10, 2026, to review the companys application for this transaction.
Related Articles
PRU (02378) spent 3.0226 million on August 3 to repurchase 271,800 shares.
GDC (08271) issues profit warning, expecting mid-term profit to decrease to no less than 2.5 million HKD.
CICC (03908): The coupon interest rate for "23 Zhongjin F1" has been reduced by 145 basis points in the last two years.
PRU (02378) spent 3.0226 million on August 3 to repurchase 271,800 shares.
GDC (08271) issues profit warning, expecting mid-term profit to decrease to no less than 2.5 million HKD.
CICC (03908): The coupon interest rate for "23 Zhongjin F1" has been reduced by 145 basis points in the last two years.
RECOMMEND
